16 related articles for article (PubMed ID: 38444861)
1. Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised "proof-of-principle" phase II study.
de Rosa F; Ridolfi L; Ridolfi R; Gentili G; Valmorri L; Nanni O; Petrini M; Fiammenghi L; Granato AM; Ancarani V; Pancisi E; Soldati V; Cassan S; Riccobon A; Parisi E; Romeo A; Turci L; Guidoboni M
J Transl Med; 2014 Jul; 12():209. PubMed ID: 25053129
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of dendritic cell-based immunotherapy (DCVAC/LuCa) combined with carboplatin/pemetrexed for patients with advanced non-squamous non-small-cell lung cancer without oncogenic drivers.
Zhong R; Ling X; Cao S; Xu J; Zhang B; Zhang X; Wang H; Han B; Zhong H
ESMO Open; 2022 Feb; 7(1):100334. PubMed ID: 34959168
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Biological Activity of Chemoimmunotherapy in Advanced Endometrial Adenocarcinoma: A Phase II Trial of the Big Ten Cancer Research Consortium.
Barber EL; Chen S; Pineda MJ; Robertson SE; Hill EK; Teoh D; Schilder J; O'Shea KL; Kocherginsky M; Zhang B; Matei D
Cancer Res Commun; 2022 Oct; 2(10):1293-1303. PubMed ID: 36388466
[TBL] [Abstract][Full Text] [Related]
4. Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer.
Chiappori AA; Williams CC; Gray JE; Tanvetyanon T; Haura EB; Creelan BC; Thapa R; Chen DT; Simon GR; Bepler G; Gabrilovich DI; Antonia SJ
Cancer Immunol Immunother; 2019 Mar; 68(3):517-527. PubMed ID: 30591959
[TBL] [Abstract][Full Text] [Related]
5. Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial.
Zemanova M; Cernovska M; Havel L; Bartek T; Lukesova S; Jakesova J; Vanasek J; Reiterer P; Kultan J; Andrasina I; Siskova L; Koubkova L; Skrickova J; Salajka F; Pesek M; Klepetko P; Beniak J; Fricke H; Kadlecova P; Korolkiewicz RP; Hraska M; Bartunkova J; Spisek R
Cancer Treat Res Commun; 2021; 28():100427. PubMed ID: 34284344
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell vaccination combined with carboplatin/paclitaxel for metastatic endometrial cancer patients: results of a phase I/II trial.
Koeneman BJ; Schreibelt G; Gorris MAJ; Hins-de Bree S; Westdorp H; Ottevanger PB; de Vries IJM
Front Immunol; 2024; 15():1368103. PubMed ID: 38444861
[TBL] [Abstract][Full Text] [Related]
7. The clinical application of cancer immunotherapy based on naturally circulating dendritic cells.
Bol KF; Schreibelt G; Rabold K; Wculek SK; Schwarze JK; Dzionek A; Teijeira A; Kandalaft LE; Romero P; Coukos G; Neyns B; Sancho D; Melero I; de Vries IJM
J Immunother Cancer; 2019 Apr; 7(1):109. PubMed ID: 30999964
[TBL] [Abstract][Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
